selected scholarly activity
-
academic article
- Cost-effectiveness analysis of a fecal microbiota transplant center for treating recurrent C.difficile infection. Journal of Infection. 2020
- Hand hygiene knowledge, attitudes, and practices among hospital inpatients: A descriptive study. American Journal of Infection Control. 48:507-510. 2020
- Precision medicine and gut dysbiosis. Healthcare Management Forum. 33:107-110. 2020
- Decreased Complexity of Serum N-glycan Structures Associates with Successful Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection. Gastroenterology. 157:1676-1678.e3. 2019
- Prolonged oral vancomycin for secondary prophylaxis of relapsing Clostridium difficile infection. BMC Infectious Diseases. 19:51. 2019
- Probing the geometry of data with diffusion Fréchet functions. Applied and Computational Harmonic Analysis. 47:935-947. 2019
- Long-term durability and safety of fecal microbiota transplantation for recurrent or refractory Clostridioides difficile infection with or without antibiotic exposure. European Journal of Clinical Microbiology and Infectious Diseases. 38:1731-1735. 2019
- Corynebacterium kroppenstedtii-Associated Granulomatous Mastitis: a Report of Two Cases. Clinical Microbiology Newsletter. 41:135-138. 2019
- Fecal transplantation for recurrent or refractory Clostridium difficile diarrhea. Cohrane Library Clinical Respiratory Journal. 2018. 2018
- Serendipitous Discovery of a Guanine-rich DNA Molecule with a Highly Stable Structure in Urea. Scientific Reports. 8:1935. 2018
- Mucosal Gene Expression in Pediatric and Adult Patients With Ulcerative Colitis Permits Modeling of Ideal Biopsy Collection Strategy for Transcriptomic Analysis. Inflammatory Bowel Diseases. 24:2565-2578. 2018
- Results From a Randomized, Placebo-Controlled Clinical Trial of a RBX2660—A Microbiota-Based Drug for the Prevention of Recurrent Clostridium difficile Infection. Clinical Infectious Diseases. 67:1198-1204. 2018
- Management of Primary and Recurrent Clostridium difficile Infection: An Update. Antibiotics. 7:54-54. 2018
- Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for Recurrence. Clinical Infectious Diseases. 67:649-656. 2018
- Current Evidence for the Management of Inflammatory Bowel Diseases Using Fecal Microbiota Transplantation. Current Infectious Disease Reports. 20:21. 2018
- Association of Medical Microbiology and Infectious Disease Canada treatment practice guidelines for Clostridium difficile infection. Official Journal of the Association of Medical Microbiology and Infectious Disease Canada. 3:71-92. 2018
- Detection of DNA Amplicons of Polymerase Chain Reaction Using Litmus Test. Scientific Reports. 7:3110. 2017
- Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study. The Lancet Infectious Diseases. 17:735-744. 2017
- Bezlotoxumab for Prevention of RecurrentClostridium difficileInfection. New England Journal of Medicine. 376:305-317. 2017
- Capturing the diversity of the human gut microbiota through culture-enriched molecular profiling. Genome Medicine. 8:72. 2016
- Surotomycin versus vancomycin forClostridium difficileinfection: Phase 2, randomized, controlled, double-blind, non-inferiority, multicentre trial. Journal of Antimicrobial Chemotherapy. 71:2964-2971. 2016
- Clearance of Vancomycin-Resistant Enterococcus Concomitant With Administration of a Microbiota-Based Drug Targeted at Recurrent Clostridium difficile Infection. Open Forum Infectious Diseases. 3:ofw133. 2016
- A Catalytic DNA Activated by a Specific Strain of Bacterial Pathogen. Angewandte Chemie Angewandte Chemie - International Edition. 55:2431-2434. 2016
- Frozen vs Fresh Fecal Microbiota Transplantation and Clinical Resolution of Diarrhea in Patients With RecurrentClostridium difficileInfection. JAMA - Journal of the American Medical Association. 315:142-142. 2016
- A Practical Method for Preparation of Fecal Microbiota Transplantation. Methods in Molecular Biology. 1476:259-267. 2016
- Fidaxomicin versus Vancomycin in the Treatment ofClostridium difficileInfection: Canadian Outcomes. Canadian Journal of Infectious Diseases Canadian Journal of Infectious Diseases and Medical Microbiology. 2016:1-8. 2016
- A Review of Management of Clostridium difficile Infection: Primary and Recurrence. Antibiotics. 4:411-423. 2015
- Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial. Gastroenterology. 149:102-109.e6. 2015
- Comparison of Clostridium difficile isolates from individuals with recurrent and single episode of infection. Anaerobe. 33:105-108. 2015
- Administration of Spores of NontoxigenicClostridium difficileStrain M3 for Prevention of RecurrentC difficileInfection. JAMA - Journal of the American Medical Association. 313:1719-1719. 2015
- Multicenter, Randomized Clinical Trial To Compare the Safety and Efficacy of LFF571 and Vancomycin for Clostridium difficile Infections. Antimicrobial Agents and Chemotherapy. 59:1435-1440. 2015
- Review of the Emerging Treatment of Clostridium difficile Infection with Fecal Microbiota Transplantation and Insights into Future Challenges. Clinics in Laboratory Medicine. 34:787-798. 2014
- The outcome and long-term follow-up of 94 patients with recurrent and refractory Clostridium difficile infection using single to multiple fecal microbiota transplantation via retention enema. European Journal of Clinical Microbiology and Infectious Diseases. 33:1425-1428. 2014
- Vancomycin-Resistant Enterococcus (VRE) Transmission and Risk Factors in Contacts of VRE Carriers. Infection Control and Hospital Epidemiology. 35:876-879. 2014
- Characterization of Methicillin-ResistantStaphylococcus aureusIsolates from Patients with Persistent or Recurrent Bacteremia. Canadian Journal of Infectious Diseases Canadian Journal of Infectious Diseases and Medical Microbiology. 25:83-86. 2014
- Navigating Long-Term Safety in Fecal Microbiota Transplantation. American Journal of Gastroenterology. 108:1538-1538. 2013
- Fecal Microbiota Transplantation for Clostridium difficile Infection: Systematic Review and Meta-Analysis. American Journal of Gastroenterology. 108:500-508. 2013
- Real-time polymerase chain reaction method for detection of toxigenic Clostridium difficile from stools and presumptive identification of NAP1 clone. Diagnostic Microbiology and Infectious Disease. 75:121-123. 2013
- Epidemiology and Outcome of Pneumonia Caused by Methicillin-Resistant Staphylococcus aureus (MRSA) in Canadian Hospitals. PLoS ONE. 8:e75171-e75171. 2013
- Fecal Transplant for Clostridium difficile —Reply. Archives of Internal Medicine A.M.A. archives of internal medicine Archives of internal medicine (Chicago, Ill. : 1908). 172:825-826. 2012
-
Fecal Transplant via Retention Enema for Refractory or Recurrent
Clostridium difficile Infection. Archives of Internal Medicine A.M.A. archives of internal medicine Archives of internal medicine (Chicago, Ill. : 1908). 172:191-191. 2012 - A Canadian Working Group Report on Fecal Microbial Therapy: Microbial Ecosystems Therapeutics. Canadian Journal of Gastroenterology. 26:457-462. 2012
- Daptomycin-Nonsusceptible, Vancomycin-Intermediate, Methicillin-ResistantStaphylococcus aureusEndocarditis. Canadian Journal of Infectious Diseases Canadian Journal of Infectious Diseases and Medical Microbiology. 23:e48-e50. 2012
- InvasiveBacillus cereusInfection in a Renal Transplant Patient: A Case Report and Review. Canadian Journal of Infectious Diseases Canadian Journal of Infectious Diseases and Medical Microbiology. 23:e109-e110. 2012
- Neuraminidase-inhibitor resistance testing for pandemic influenza A (H1N1) 2009 in Ontario, Canada. Journal of Clinical Virology. 50:257-261. 2011
- A Randomized Clinical Trial of Immunization With Combined Hepatitis A and B Versus Hepatitis B Alone for Hepatitis B Seroprotection in Hemodialysis Patients. AMERICAN JOURNAL OF KIDNEY DISEASES. 56:713-719. 2010
- Prevention ofClostridium difficileInfection withSaccharomyces boulardii: A Systematic Review. Canadian Journal of Gastroenterology. 23:817-821. 2009
- Coccidioides Immitis: Two Cases of Misidentified Mycosis. Canadian Respiratory Journal. 15:377-379. 2008
- Fever in Returning Travellers Due to a Noninfectious Disease: Two Case Reports. Canadian Journal of Infectious Diseases Canadian Journal of Infectious Diseases and Medical Microbiology. 19:253-255. 2008
- Comparison of the RIDASCREEN® norovirus enzyme immunoassay to IDEIA NLV GI/GII by testing stools also assayed by RT-PCR and electron microscopy. Journal of Virological Methods. 141:216-219. 2007
- Treatment of Candiduria with Micafungin: A Case Series. Canadian Journal of Infectious Diseases Canadian Journal of Infectious Diseases and Medical Microbiology. 18:149-150. 2007
- Prospective, Randomized Inpatient Study of Oral Metronidazole versus Oral Metronidazole and Rifampin for Treatment of Primary Episode ofClostridium difficile–Associated Diarrhea. Clinical Infectious Diseases. 43:547-552. 2006
- Rat-bite fever, Canada.. Emerging Infectious Diseases. 12:1301-1302. 2006
- Concomitant information in bioassay and semi-parametric estimation. Statistics in Medicine. 24:1421-1433. 2005
- Overwhelming Pulmonary Infection after a Tobogganing Accident. Canadian Journal of Infectious Diseases Canadian Journal of Infectious Diseases and Medical Microbiology. 16:253-254. 2005
- Clinical Outcome with Oral Linezolid and Rifampin Following Recurrent Methicillin-ResistantStaphylococcus aureusBacteremia Despite Prolonged Vancomycin Treatment. Canadian Journal of Infectious Diseases Canadian Journal of Infectious Diseases and Medical Microbiology. 15:97-100. 2004
- Myocarditis related to Campylobacter jejuniinfection: A case report. BMC Infectious Diseases. 3:16. 2003
- A 44-year-old woman with dry cough and solitary nodule.. CMAJ. 169:696-697. 2003
- An elderly man with nonresolving cough, leukocytosis and a pulmonary mass.. CMAJ. 169:134-135. 2003
- Acute hepatitis associated with oral levofloxacin therapy in a hemodialysis patient.. CMAJ. 168:847-848. 2003
-
conference paper
- There Is No Association Between Patient Outcomes and Demographics in an Open-Label Safety and Efficacy Study of RBX2660, a Microbiota-Based Drug for Recurrent Clostridium difficile Infection. American Journal of Gastroenterology. S66-S66. 2017
- The central role of the intestinal microbiota in chronic intestinal pseudo-obstruction. Neurogastroenterology and Motility. 16-16. 2016
- Su1905 Fecal Microbiome Profiles of Ulcerative Colitis Patients With and Without Anxiety and/or Depression. Gastroenterology. S584-S585. 2016
- The Gut Microbiome in Patients with Anxiety, Depression and Inflammatory Bowel Disease. Neuropsychopharmacology. S289-S289. 2014
- A randomized, placebo controlled trial of fecal microbiota therapy in active ulcerative colitis.. Gastroenterology. S159-S159. 2014
- Investigating the microbiome pre and post fecal microbiota therapy from active ulcerative colitis patients in a randomized placebo controlled trial. Gastroenterology. S902-S902. 2014
- Microcystic Stromal Tumor of the Ovary:A Distinct Ovarian Stromal Neoplasm Characterized by FOXL2, SF-1, WT-1, Cyclin D1, and beta-Catenin Nuclear Expression and CTNNB1 Mutations. Modern Pathology. 287A-287A. 2014
- Analysis of spatial and temporal variability of Enterococci concentration at Santa Monica Municipal Pier, California. ACS National Meeting Book of Abstracts. 2010
- A multiplex real-time PCR method for presumptive identification of NAP1 clone of Clostridium difficile from stools. International Journal of Infectious Diseases. e365-e365. 2010
- O5 Utility of Gram stain and cell counts for diagnosing septic arthritis. International Journal of Antimicrobial Agents. S2-S2. 2009